Associated Papers
Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors.
Brenner BG et al.
The Journal of Antimicrobial Chemotherapy, 2016
Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors.
Low A et al.
Antimicrobial Agents and Chemotherapy, 2009
Select a paper to view details